Product Information
ABIRATERONE ACETATE 500 MG TAB is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $2.5944 per EA under NDC 82009014060. Its NADAC has been published 91 times since Jan 8, 2025.
FDA first approved this application on Jul 10, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Quallent Pharmaceuticals Health LLCNDC
82009014060
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ABIRATERONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA210686FDA Approved
7/10/2019
TE Code
AB
On Market Since
10/7/2019
Pharmacological Classes
Price Statistics
The NADAC for ABIRATERONE ACETATE 500 MG TAB has been published 91 times since Jan 8, 2025, and over the history we have for it it has declined 81.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.5944 per EA |
|---|---|
| All-time high | $17.6906 (May 14, 2025) |
| All-time low | $2.5944 (Sep 23, 2026) |
| 52-week high | $9.0056 |
| 52-week low | $2.5944 |
| Median price | $5.2444 |
| Average price | $8.6513 |
| Largest weekly change | -39.2% (Oct 22, 2025) |
| Weeks tracked | 91 |
| Tracking since | Jan 8, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Quallent Pharmaceuticals Health LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Abiraterone acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cytochrome P450 17A1 Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ABIRATERONE ACETATE 500 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ABIRATERONE ACETATE 500 MG TAB, manufactured by Quallent Pharmaceuticals Health LLC, is $2.5944 per EA (NDC 82009014060), effective Sep 30, 2026.
How has the price of ABIRATERONE ACETATE 500 MG TAB changed over time?
Over the history we have for it, the NADAC for ABIRATERONE ACETATE 500 MG TAB has declined 81.5%. It has been tracked across 91 weekly CMS publications since Jan 8, 2025.
What are the highest and lowest recorded NADAC prices for ABIRATERONE ACETATE 500 MG TAB?
Since Jan 8, 2025, the NADAC for ABIRATERONE ACETATE 500 MG TAB has ranged from a low of $2.5944 (Sep 23, 2026) to a high of $17.6906 (May 14, 2025), with a median of $5.2444 per EA.
Are there cheaper alternatives to ABIRATERONE ACETATE 500 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ABIRATERONE ACETATE 500 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures ABIRATERONE ACETATE 500 MG TAB?
ABIRATERONE ACETATE 500 MG TAB (NDC 82009014060) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.